Lantheus Holdings
LNTH • NASDAQ
Lantheus Holdings is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Mary Anne Heino, with a market cap of $5.3B.
Market Cap$5.3B
Employees834.0
CEOMary Anne Heino
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 6, 2026 · In 1 weekBefore Market Open · Q1 2026
Financials
Lantheus Holdings FAQ
Common questions about Lantheus Holdings
Lantheus Holdings is scheduled to report earnings for Q1 2026 on May 6, 2026 before market open. Analysts estimate revenue of $354.9M.
Lantheus Holdings has approximately 834 employees.